Novartis AG (Sp.ADRs) revenue for the last year amounted to 48.61 B EUR, the most of which — 14.24 B EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 12.31 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Novartis AG (Sp.ADRs) 20.43 B EUR, and the year before that — 16.27 B EUR.